G
Great Bay Bio
Provides technical services concerning CMC and AI biologics and develops biomedical products
About Great Bay Bio
Great Bay Bio is a biotechnology company specializing in bioprocessing solutions that accelerate drug development. The company leverages artificial intelligence (AI) to enhance the efficiency and effectiveness of bioprocessing, which is the use of living cells or their components to obtain desired products. Great Bay Bio serves pharmaceutical companies and research institutions, providing them with cutting-edge tools to streamline the development of biologics, which are drugs derived from living organisms. Operating in the biopharmaceutical market, the company employs a business model that includes both service-based and product-based revenue streams. It makes money by offering technical services and selling proprietary bioprocessing products.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 32
- Open positions
- 3
- Dealroom signal
- 78.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Drug Development, Core AI, Biotech and Pharma, AI Drug Discovery, Techbio, AI Applications, biomanufacturing
- Technology
- Artificial Intelligence, Deep Tech
- Business model
- Manufacturing
- Client focus
- B2B
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Dec 2024 | — | — | Tiger Jade Capital · Hong Kong Science & Technology Parks Corporation | ↗ |
| EARLY VC✓Equity / VC | Sep 2022 | $15M | $60M | Alon Capital · AEF Greater Bay Area Venture Fund · Vectr Ventures · Alibaba Entrepreneurs Fund | ↗ |
Growth signals
Latest recorded traffic for Great Bay Bio is 510 monthly website visits, up 8.5% over the last three months. Great Bay Bio's team grew 3.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Great Bay Bio in the Central and Western District ecosystem
The Great Bay Bio office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A13 investors entered at this stage
Futec International
Fengde Capital
Alibaba Entrepreneurs Fund
Hillhouse Capital
Proxima Ventures- ACAlon Capital
FutureX Capital
GL Ventures
Tiger Jade Capital- AFAEF Greater Bay Area Venture Fund
Vectr Ventures
Gobi Partners
Hong Kong Science & Technology Parks Corporation
Other known investors2 additional known investors
- ACAaron Capital
Alibaba
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Great Bay Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Great Bay Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








